Wilmington, Delaware- Bayard has been selected to serve as co-counsel to the Official Committee of Unsecured Creditors (the “Committee”) in In re Insys Therapeutics, Inc., et al., (Case No. 19-11292 (KG)), filed on June 10, 2019 in the United States Bankruptcy Court for the District of Delaware. On June 19, 2019, the Office of the United States Trustee formed the Committee. After its formation, the Committee selected Akin Gump Strauss Hauer & Feld, LLP and Bayard, P.A. as its legal counsel and Province, Inc. as its financial advisor.

Bayard attorneys Justin R. Alberto, Erin R. Fay, Daniel N. Brogan, Gregory J. Flasser, and Sophie E. Macon are involved in the matter.

Insys Therapeutics and its debtor affiliates operate a specialty pharmaceutical company that manufactures and markets, among other products, Subsys™, a sublingual fentanyl spray. Insys is the first opioid manufacturer to file for Chapter 11 protection amidst the nationwide opioid crisis Insys and its debtor affiliates filed for chapter 11 protection following criminal convictions of former management and only ten days after reaching a $225 million settlement with the US Justice Department.
Insys Therapeutics, Inc. operates a website at https://www.insysrx.com/.